| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.003 |